Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.45 USD | +3.40% | +8.58% | +192.27% |
Apr. 04 | Avidity Biosciences Insider Sold Shares Worth $734,919, According to a Recent SEC Filing | MT |
Apr. 04 | Avidity Biosciences Insider Sold Shares Worth $542,214, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 13.46M | Sales 2025 * | 10.5M | Capitalization | 2.53B |
---|---|---|---|---|---|
Net income 2024 * | -270M | Net income 2025 * | -316M | EV / Sales 2024 * | 134 x |
Net cash position 2024 * | 722M | Net cash position 2025 * | 431M | EV / Sales 2025 * | 200 x |
P/E ratio 2024 * |
-8.43
x | P/E ratio 2025 * |
-7.49
x | Employees | 253 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.63% |
Latest transcript on Avidity Biosciences, Inc.
1 day | +3.40% | ||
1 week | +8.58% | ||
Current month | +9.61% | ||
1 month | -0.71% | ||
3 months | +127.43% | ||
6 months | +383.55% | ||
Current year | +192.27% |
Managers | Title | Age | Since |
---|---|---|---|
Troy Wilson
FOU | Founder | 55 | 12-11-12 |
Sarah Boyce
CEO | Chief Executive Officer | 52 | 19-09-30 |
Michael MacLean
DFI | Director of Finance/CFO | 58 | 20-05-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Levin
BRD | Director/Board Member | 70 | 13-09-30 |
Carsten Boess
BRD | Director/Board Member | 57 | 20-04-12 |
Edward Kaye
BRD | Director/Board Member | 74 | 19-08-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 26.45 | +3.40% | 641,653 |
24-05-02 | 25.58 | -0.85% | 558,573 |
24-05-01 | 25.8 | +6.92% | 1,167,144 |
24-04-30 | 24.13 | -2.31% | 1,064,650 |
24-04-29 | 24.7 | +1.40% | 640,595 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+192.27% | 2.53B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-4.33% | 8.5B |
- Stock Market
- Equities
- RNA Stock